查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球真皮填充劑市場（按性別、按材料、按最終用戶、按分銷管道、按主要地區）：行業趨勢和預測（2023-2035）
市場調查報告書
商品編碼
1411404

全球真皮填充劑市場（按性別、按材料、按最終用戶、按分銷管道、按主要地區）：行業趨勢和預測（2023-2035）

Dermal Fillers Market, 2023-2035 - Distribution by Gender, by Material, End User, Distribution Channel and Key Geographical Regions : Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

到 2023 年，全球真皮填充劑市場價值將達到 30 億美元，在預測期內（2023-2035 年）複合年增長率為 9%。

在瞬息萬變的醫美世界中，跟上最新趨勢已成為開發商和消費者的首要任務。 真皮填充劑，也稱為臉部填充劑，是一種可注射的治療方法，含有凝膠狀物質形式的透明質酸。 皮膚填充劑最近已成為消費者最追捧的臉部年輕化、即時臉部提升、疤痕治療和唇部增強的選擇之一。 根據 IAPS 的數據，2022 年全球進行了超過 430 萬例透明質酸真皮填充手術。 這主要是因為該手術是微創的，適合許多尋求整容手術的患者。 在某些情況下，這些手術可能是非侵入性的（很少或沒有疼痛）。

真皮填充劑一般由玻尿酸、乳酸、羥基磷灰石鈣和聚甲基丙烯酸甲酯凝膠製成。 真皮填充劑通常皮下注射到臉部區域，例如法令紋（法令紋）、木偶紋、臉頰和口腔連合處。 治療不需要麻醉。 治療持續時間從 5 個月到 5 年不等，具體取決於所使用的材料。 科學家們正在透過使用插管技術徹底改變真皮填充劑市場。 插管技術減少了手術的侵入性，最大限度地減少了瘀傷，並允許精確放置填充物。 技術進步也促進了下一代填料的開發。 這些填料具有更好的交聯性能並提供更持久的效果。 由於對真皮填充劑治療的需求不斷增長以及每年需要真皮填充劑治療的患者數量不斷增加，因此預計真皮填充劑注射市場將在預測期內增長。

本報告分析了全球真皮填充劑市場，提供了產品概述、市場基本結構和最新情況、主要市場推動和限制因素、整體市場規模趨勢展望、細分市場和我們調查按地區（共5個地區）的詳細趨勢、近期主要業務聯盟及資本交易動向（投資、併購等）、當前競爭狀況、主要公司概況等。

主要細分市場

依性別

  • 男性
  • 女性

依材質

  • 玻尿酸填充劑
  • 非玻尿酸填充劑

按最終使用者

  • 醫院
  • 診所/醫療水療中心、皮膚科/美容中心
  • 其他最終用戶

依銷售管道

  • 直接銷售
  • 間接銷售

依主要地區劃分

  • 北美洲（美國、加拿大、墨西哥）
  • 歐洲（英國、德國、法國、義大利、西班牙等）
  • 亞太地區（中國、韓國、日本、印度）
  • 中東/北非（土耳其、伊朗等）
  • 拉丁美洲（巴西、阿根廷等）

主要市場參與者

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

目錄

第一章簡介

第二章研究方法

第 3 章經濟趨勢和其他特定於項目的考量

第 4 章執行摘要

第 5 章簡介

  • 醫美理念
  • 醫學美學的演變
  • 真皮填充劑
  • 真皮填充劑的優點
  • 真皮填充劑的副作用
  • 醫美主要促進生長因素
  • 最新醫療美容技術
  • 醫學美容的主要挑戰
  • 未來前景

第六章市場狀況

  • 真皮填充劑：市場狀況

第七章公司簡介

  • 艾爾建美學
  • 克羅馬製藥
  • 高德瑪
  • IBSA
  • 辛克萊製藥

第八章企業競爭力分析

  • 主要假設和參數
  • 調查方法
  • 醫學美學：企業競爭力分析

第 9 章夥伴關係與協作

  • 合作夥伴模式
  • 真皮填充劑：夥伴關係與協作
  • 按地區分析

第十章融資與投資

  • 融資模式
  • 真皮填充劑：融資與投資
  • 結論

第十一章市場影響分析：促進因素、限制因素、機會與挑戰

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場挑戰
  • 結論

第十二章全球真皮填充劑市場

  • 主要假設與研究方法
  • 全球真皮填充劑市場：過去趨勢（2018-2022）與未來預測（2023-2035）
  • 主要細分市場
  • 動態儀表板

第 13 章皮膚填充劑市場，依最終用戶劃分

  • 主要假設與研究方法
  • 真皮填充劑市場：依最終使用者劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第 14 章真皮填充劑市場：依性別

  • 主要假設與研究方法
  • 真皮填充劑市場：依性別分類（2018、2023、2035）
  • 數據測量與驗證

第 15 章皮膚填充劑市場，依通路劃分

  • 主要假設與研究方法
  • 真皮填充劑市場，依通路劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第十六章真皮填充劑市場：依主要地區劃分

  • 主要假設與研究方法
  • 真皮填充劑市場：依主要地區劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第十七章真皮填充劑產品市場

  • 主要假設與研究方法
  • 全球真皮填充劑產品市場：過去趨勢（2018-2022）與未來預測（2023-2035）
  • 依主要地區劃分的真皮填充劑產品市場（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第 18 章管理見解

第十九章結論

第 20 章附錄 1：表格資料

第 21 章附錄 2：公司與組織名單

簡介目錄
Product Code: RA100471

The dermal fillers market is valued at USD 3 billion in 2023 growing at a CAGR of 9% during the forecast period 2023-2035.

In the ever-changing world of medical aesthetics, staying up to date with the latest trends has become a priority for both the developers and the consumers. Dermal fillers are injectable treatments that contain hyaluronic acids in the form of gel-like substances. They are also called facial fillers. In recent years, dermal fillers have become one of the most sought-after options among consumers when it comes to facial rejuvenation, instant facial lift, scar treatment, and lip enhancement. According to IAPS, in 2022, more than 4.3 million Hyaluronic acid Dermal Filler procedures were performed worldwide. This is largely due to the fact that the procedure is minimally invasive, making it suitable for a large number of patients seeking cosmetic procedures. In some cases, these procedures can be non-invasive, meaning they involve minimal or no pain.

Dermal fillers are generally made up of hyaluronic acids, lactic acids, calcium hydroxyapatite and polymethyl methacrylic acid gels. Dermal fillers are usually injected under the skin in the following areas of the face: nasolabial fold, marionette line, cheeks, oral commissures, etc. Treatment does not require anesthesia. The duration of the treatment can range from 5 months up to 5 years depending on the material used. Scientists are revolutionizing the field of Dermal Fillers market by using cannula technique. Cannula technique involves the use of a blunt tip cannula despite the presence of a needle for the injection of fillers. This approach reduces the invasive nature of the procedure, minimizes bruising, and allows for precise placement of fillers. Technological advances have also enabled the development of next generation fillers. These fillers have better cross-linking characteristics and provide longer lasting results. With the growing demand and increasing number of patients requiring dermal filler treatments every year, the dermal filler injection market is expected to grow over the forecast period.

Key Market Segments

Gender

  • Male
  • Female

Material

  • Hyaluronic Fillers
  • Non-Hyaluronic Acid Fillers

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users

Distribution Channel

  • Direct Distribution
  • Indirect Distribution

Key Geographical Regions

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, South Korea, Japan, India)
  • Middle East and North Africa (Turkey, Iran, Rest of the Middle East and North Africa)
  • Latin America (Brazil, Argentina, Rest of the Latin America)

Research Coverage:

The report studies the dermal fillers market based on gender, material, end user, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including dermal fillers, benefits and drawbacks of these procedures. Further, the chapter also covers the new technologies applied in this field.

Comprehensive analysis of the current landscape of dermal filler developers considering parameters such as establishment year, company size, headquarters, application area and end user

In-depth profiles of companies offering dermal filler procedures products and / or devices, focusing on company overviews, financial information (where available), offered dermal filler procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of dermal filler company, considering various parameters.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics dermal fillers companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the dermal fillers market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Inclusions and Exclusions
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Ris
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Dermal Fillers
  • 5.5. Advantages of Dermal Fillers
  • 5.6. Side Effects of Dermal Fillers
  • 5.7. Key Growth Drivers of Medical Aesthetics
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Dermal Fillers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Application Area
    • 6.2.8. Analysis by End-user

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Allergan Aesthetics
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Medical Aesthetics Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Croma Pharma
    • 7.3.1. Company Overview
    • 7.3.2. Financial Information
    • 7.3.3. Medical Aesthetics Portfolio
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Galderma
    • 7.4.1. Company Overview
    • 7.4.2. Financial Information
    • 7.4.3. Medical Aesthetics Portfolio
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. IBSA
    • 7.5.1. Company Overview
    • 7.5.2. Medical Aesthetics Portfolio
    • 7.5.3. Recent Developments and Future Outlook
  • 7.6. Sinclair Pharma
    • 7.6.1. Company Overview
    • 7.6.2. Medical Aesthetics Portfolio
    • 7.6.3. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Dermal Fillers: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Dermal Fillers: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.9. Analysis by Company Size and Amount Invested
    • 10.3.10. Leading Investors: Analysis by Number of Funding Instances
  • 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. GLOBAL DERMAL FILLERS MARKET

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Dermal Fillers Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 12.3.1. Scenario Analysis
      • 12.3.1.1. Conservative Scenario Analysis
      • 12.3.1.2. Optimistic Scenario Analysis
  • 12.4. Key Market Segmentations
  • 12.5. Dynamic Dashboards

13. DERMAL FILLERS MARKET, BY END-USER

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035
    • 13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

13.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

    • 13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 13.4. Data Triangulation and Validation

14. DERMAL FILLERS MARKET, BY GENDER

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Dermal Fillers Market: Distribution by Gender, 2018, 2023 and 2035
    • 14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Dermal Fillers Market, by Distribution Channel, 2015, 2023 and 2035
    • 15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. DERMAL FILLERS MARKET, BY KEY GEOGRAPHICAL REGION

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Dermal Fillers Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
    • 16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. DERMAL FILLERS PRODUCT MARKET

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Global Dermal Fillers Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Dermal Fillers Products Market, by Key Geographical Regions, 2018, 2023 and 2035
    • 17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Data Triangulation and Validation

18. EXECUTIVE INSIGHTS

19. CONCLUSION

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS